Search Results

Displaying Results 2851-2875 of 27195 "'C'"

Aug 12, 2026, 08:42 ET HealthWorX Calls for a New Healthcare Operating Model as Coverage Fails to Become Care

conventional approach for essential primary care with a model organized around access, mission, and execution. Under the nonprofit-TPA structure, a private 501(c)(3) public charity subsidizes no-cost primary care. A separate TPA administers eligibility, enrollment, claims, reporting, provider arrangements, and

More news about: HealthWorX


Aug 12, 2026, 08:30 ET Vanguard's New Customizable Model Portfolios Streamline Portfolio Personalization for Financial Advisors

investor outcomes."As part of the offering, Vanguard is working with Vestmark's wealthtech platform, the turnkey asset management platform from SS&C Black Diamond® Wealth Solutions, and Orion's Tailored Allocation Portfolios to help advisors and firms implement Vanguard Custom Model

More news about: Vanguard


Aug 12, 2026, 08:30 ET Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease

capital fund founded in 2017 and backed by Eyal Ofer's Ofer Global, and focused primarily on early growth-stage investments, typically in Series B and C rounds. OGVP manages over $1.5 billion in assets under management (AUM). Its active portfolio includes companies such as Lendbuzz, Coralogix, Via, Neko

More news about: Remepy


Aug 12, 2026, 08:30 ET Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living with Tardive Dyskinesia

clinician- and patient-reported changes in TD severity using the Abnormal Involuntary Movement Scale (AIMS), the Patient Global Impression of Change (PGI-C) and the Clinical Global Impression of Severity-TD (CGI-TD-S). Fifty-nine patients were enrolled in the KINECT-PRO study and received once-daily INGREZZA

More news about: Neurocrine Biosciences, Inc.


Aug 12, 2026, 08:03 ET Pudu Robotics Launches PUDU ET1, an AI-Native Compact Scrubber-Dryer Robot for Small Commercial Spaces

efficiently recovering dirt and wastewater. For sticky stains commonly found in restaurants, convenience stores and retail spaces, ET1 supports 85°C hot scrubbing, with hot water supplied by the docking station and maintained by the robot during operation.ET1 also features real-time roller

More news about: Pudu Robotics


Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

candidate, ibezapolstat, for the treatment of C. difficile Infection (CDI) is Phase 3 ready to advance to international clinical trials subject to obtaining appropriate financing. Acurx has received FDA guidance in meeting minutes from a July 13, 2026 Type C Meeting to discuss ibezapolstat's (IBZ) Phase

More news about: Acurx Pharmaceuticals, Inc.


Aug 12, 2026, 08:01 ET AI Agents are Only the Beginning: Deloitte Survey Examines the AI Readiness Gap and Reveals How Enterprises Can Prepare for Agentic Success

transformation.About the surveyThe insights and statistics included in this report came from a survey that was fielded to 501 senior manager- to C-suite-level respondents, based in the United States, across five industries between April and June 2026. All organizations participating in the survey

More news about: Deloitte


Aug 12, 2026, 08:00 ET Skan AI Raises $63 Million to Give Enterprise AI the Context It's Missing: How Work Actually Gets Done

can help businesses improve collaboration, increase productivity and helps maximize the value of technologies used every day."Watch the Series C announcement:

More news about: Skan AI


Aug 12, 2026, 08:00 ET Pudu Robotics Launches PUDU ET1, an AI-Native Compact Scrubber-Dryer Robot for Small Commercial Spaces

efficiently recovering dirt and wastewater. For sticky stains commonly found in restaurants, convenience stores and retail spaces, ET1 supports 85°C hot scrubbing, with hot water supplied by the docking station and maintained by the robot during operation.ET1 also features real-time roller

More news about: Pudu Robotics


Aug 12, 2026, 08:00 ET Leading Independent Proxy Advisory Firm ISS Recommends LivePerson Stockholders Vote "FOR" Proposed Transaction with SoundHound AI

shares listed on the Tel Aviv Stock Exchange (TASE) and intend to vote their shares must deliver to LivePerson's Israeli counsel, Arnon, Tadmor-Levy, c/o Moshe Pasker, Azrieli Center (Square Tower), Tel Aviv, Israel, 6702101 (email: [email protected]),

More news about: LivePerson, Inc.


Aug 12, 2026, 07:49 ET Mach Travel Solutions Ltd Q1 FY27 Revenue Jumps 538% YoY to ₹144.33 Crore

technology-enabled travel solutions platform spanning Corporate Travel, MICE, B2B, Leisure and Government & Institutional Projects, while also developing a B2C Online Travel Agency (OTA) platform.During the quarter, Mach executed large domestic and international mandates, including MICE programmes across

More news about: Mach Travel Solutions Limited


Aug 12, 2026, 07:39 ET Mach Travel Solutions Ltd Q1 FY27 Revenue Jumps 538% YoY to ₹144.33 Crore

technology-enabled travel solutions platform spanning Corporate Travel, MICE, B2B, Leisure and Government & Institutional Projects, while also developing a B2C Online Travel Agency (OTA) platform.During the quarter, Mach executed large domestic and international mandates, including MICE programmes across

More news about: Mach Travel Solutions Limited


Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

need.Reached FDA alignment on registrational Phase 3 trial in DKK1-high colorectal cancer Leap Therapeutics held a Type C meeting with the FDA to discuss the DeFianCe results and proposed registrational path for sirexatamab in DKK1-high, second-line mCRC. Leap presented its

More news about: Cypherpunk Technologies Inc.


Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

need.Reached FDA alignment on registrational Phase 3 trial in DKK1-high colorectal cancer Leap Therapeutics held a Type C meeting with the FDA to discuss the DeFianCe results and proposed registrational path for sirexatamab in DKK1-high, second-line mCRC. Leap presented its

More news about: Cypherpunk Technologies Inc.


Aug 12, 2026, 07:00 ET Healthcare CFOs Face a Wide Readiness Gap as Business Performance and AI Value Expectations Rise, Deloitte Survey Finds

readiness gap between healthcare CFO expectations and enablement may be an organizational design gap. Finance leaders should be involved early with their C-suite colleagues and with access to the information involved in influencing decisions and help translate strategy into results that deliver on business

More news about: Deloitte LLP


Aug 12, 2026, 07:00 ET Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

Ltd., a market leader in organ preservation solutions and perfusion technologies, today announced the successful completion of a $110 million Series C and debt financing. The equity financing was led by new investor Soleus Capital, along with Lauxera Capital Partners and participation by Bridge to Life

More news about: Bridge to Life, Ltd.


Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

States and for overall survival to support full approval in the United States and registration in other markets; the significance of the Company's Type C meeting with the FDA and any alignment reached with the Agency; the definition, validation and prevalence of the DKK1-high patient population and the

More news about: Cypherpunk Technologies Inc.


Aug 12, 2026, 06:58 ET 騰訊公佈二零二六年第二季業績

3,134現金淨額 (c)58,191

More news about: 騰訊


Aug 12, 2026, 06:55 ET Trimble Announces Second Quarter 2026 Results and Raises Full Year Guidance

compensation / deferred compensation(C)3.8

More news about: Trimble


Aug 12, 2026, 06:50 ET 넥스티어의 하이마운트 다이렉트 드라이브 액추에이터, 소프트웨어 정의 차량을 위한 콕핏 설계 자유도 확보

multimedia:https://www.prnewswire.com/kr/news-releases/uB125uC2A4uD2F0uC5B4uC758u002DuD558uC774uB9C8uC6B4uD2B8u002DuB2E4uC774uB809uD2B8u002DuB4DCuB77CuC774uBE0Cu002DuC561uCD94uC5D0uC774uD130u002C-302849629.htmlSOURCE

More news about: Nexteer Automotive


Aug 12, 2026, 06:30 ET Valens Semiconductor Reports Strong Second Quarter 2026 Results and Raises Full-Year Revenue Guidance

Q2 2026 Business Highlights: Barco selected HDBaseT chipsets to power its new ClickShare USB-C Extension over CAT kit.Participated at the InfoComm trade show, showcasing the VS3000 and the VS6320 chipsets, expanding engagements, and generating

More news about: Valens Semiconductor


Aug 12, 2026, 06:15 ET Epson Wins Two Awards from Spaces4Learning for its Inkjet Printers for Education

Epson EM-C800 and AM-C550z earn Platinum recognition in the 2026 Spaces4Learning New Product AwardsSpaces4Learning is a leading industry resource for education

More news about: Epson America, Inc.


Aug 12, 2026, 05:03 ET nubia Neo 5 Max with 7.5-Inch Display Lands as a New PadPhone Category

4.7ms hardware response latency for fast execution across aiming, firing, moving, and skill activation in a flexible four-finger mode. Designed around C-grip holding style, its 7.5-inch golden control ratio expands the touch area by 27% and widens key spacing by 21% over conventional layouts. Magic Touch

More news about: ZTE Corporation


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.